tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market
HOWL
Werewolf Therapeutics
RESEARCH TOOLSreports

Werewolf Therapeutics (HOWL) Income Statement

789 Followers

Werewolf Therapeutics Income Statement

Last quarter (Q4 2025), Werewolf Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Werewolf Therapeutics's net income was $-8.38M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 1.89M$ 19.94M$ 16.40M$ 0.00
Gross Profit
$ -1.63M$ 71.00K$ 18.18M$ 13.89M$ 0.00
Operating Expenses
$ 59.04M$ 73.67M$ 58.68M$ 69.95M$ 50.09M
Depreciation and Amortization
$ 1.63M$ 1.81M$ 1.76M$ 2.51M$ 216.00K
EBITDA
$ -59.04M$ -64.05M$ -32.47M$ -51.30M$ -49.87M
Operating Income
$ -60.68M$ -73.59M$ -40.50M$ -56.06M$ -50.09M
Other Income/Expenses
$ -145.00K$ 3.08M$ 3.13M$ 2.25M$ 104.00K
Pretax Income
$ -60.82M$ -70.52M$ -37.37M$ -53.81M$ -49.98M
Net Income
$ -60.82M$ -70.52M$ -37.37M$ -53.81M$ -49.98M
Per Share Metrics
Basic EPS
$ -1.32$ -1.63$ -1.05$ -1.86$ -10.94
Diluted EPS
$ -1.33$ -1.63$ -1.05$ -1.86$ -10.94
Weighted Average Shares Outstanding
 46.02M 43.33M 35.65M 28.86M 18.45M
Weighted Average Shares Outstanding (Diluted)
 46.81M 43.86M 35.65M 28.86M 18.45M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History